Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells

Laura M. Kasman, Sutapa Barua, Ping Lu, Kaushal Rege, Christina Voelkel-Johnson

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The application of adenoviral gene therapy for cancer is limited by immune clearance of the virus as well as poor transduction efficiency, since the protein used for viral entry (CAR) serves physiological functions in adhesion and is frequently decreased among cancer cells. Cationic polymers have been used to enhance adenoviral gene delivery, but novel polymers with low toxicity are needed to realize this approach. We recently identified polymers that were characterized by high transfection efficiency of plasmid DNA and a low toxicity profile. In this study we evaluated the novel cationic polymer EGDE-3,3′ for its potential to increase adenoviral transduction of the CAR-negative bladder cancer cell line TCCSUP. The amount of adenovirus required to transduce 50-60% of the cells was reduced 100-fold when Ad.GFP was preincubated with the EGDE-3,3′ polymer. Polyethyleneimine (pEI), a positively charged polymer currently used as a standard for enhancing adenoviral transduction, also increased infectivity, but transgene expression was consistently higher with EGDE-3,3′. In addition, EGDE-3,3′-supplemented transduction of an adenovirus expressing an apoptosis inducing transgene, Ad.GFP-TRAIL, significantly enhanced the amount of cell death. Thus, our results indicate that novel biocompatible polymers may be useful in improving the delivery of adenoviral gene therapy.

Original languageEnglish (US)
Pages (from-to)1612-1619
Number of pages8
JournalMolecular Pharmaceutics
Volume6
Issue number5
DOIs
StatePublished - Oct 5 2009

Keywords

  • Adenovirus
  • Bladder cancer
  • Cancer
  • Gene therapy
  • Polymer

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Fingerprint Dive into the research topics of 'Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells'. Together they form a unique fingerprint.

Cite this